Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_4

25%

Ph phase_1

25%

Ph phase_2

25%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Other(1)

Detailed Status

Completed3

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (25.0%)

Phase 21 (25.0%)

Phase 41 (25.0%)

N/A1 (25.0%)

Trials by Status

completed375%

unknown125%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_4

The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS

NCT01961180

completednot_applicable

Clinical Trials (4)

Showing 4 of 4 trials

NCT01961180Phase 4

The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS

Completed

NCT01644071Not Applicable

Serotonergic System and Violent Video Games

Completed

NCT00485888Phase 2

Flushing in Social Anxiety Disorder on Cipralex

Completed

NCT01293838Phase 1

Cipralex® for Anxiety Disorders in Adolescents

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4